Moderna, together with the National Institute of Allergy and Infectious Diseases (NIAID), sent mRNA coronavirus vaccine candidates to the University of North Carolina at Chapel Hill on December 12, 2019 — raising significant red flags.
In confidential documents3 revealed by the U.K.’s Daily Expose, Moderna, and NIAID, sent mRNA coronavirus vaccine candidates to the University of North Carolina at Chapel Hill December 12, 2019. As The Daily Expose reported:4
“What did Moderna [and NIAID] know that we didn’t? In 2019 there was not any singular coronavirus posing a threat to humanity which would warrant a vaccine, and evidence suggests there hasn’t been a singular coronavirus posing a threat to humanity throughout 2020 and 2021 either.”
The providers agreed to transfer “mRNA coronavirus vaccine candidates developed and jointly-owned by NIAID and Moderna” to the university’s investigator and was signed by Ralph Baric.
Baric pioneered techniques for genetically manipulating coronaviruses, which became a major focus for research at the Wuhan Institute of Virology (WIV).
Baric worked closely with WIV’s Shi Zhengli, Ph.D., on research using genetic engineering to create a “new bat SARS-like virus ... that can jump directly from its bat hosts to humans”.
Serious questions need to be answered, including: Were Moderna, NIAID and Baric aware that COVID-19 was circulating in mid-December 2019, or did they have knowledge far before that such a vaccine would soon be in demand?